nmet LDL-C target in very high risk cardiovascular patients
Phase 4
Completed
- Conditions
- <tr><td>Hyperlipidaemia/high cholesterol post myocardial infarction</td></tr>10011082
- Registration Number
- NL-OMON21157
- Lead Sponsor
- WC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 1000
Inclusion Criteria
|
- Opname voor ACS: (N)STEMI type I |
Exclusion Criteria
|
- Leeftijd <18 jaar |
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br><tr><br><td>Study endpoint:<br /><br><br /><br>- Proportion of patients with LDL-C >1.8 mMol/L during stepwise incremental lipid modifying therapy with respectively a statin, statin + ezetimibe.</td><br></tr><br>
- Secondary Outcome Measures
Name Time Method